Tazomac 2.25 g Injection is a potent pharmaceutical formulation designed for effective therapeutic intervention. This injection contains a carefully balanced composition that primarily includes tazobactam and piperacillin, making it a combination antibiotic that targets a wide range of bacterial infections. Tazomac 2.25 g Injection falls under the category of beta-lactam antibiotics, which are known for their efficacy in treating serious infections caused by susceptible organisms. The primary purpose of Tazomac 2.25 g Injection is to combat infections that are resistant to other antibiotics, providing healthcare professionals with a reliable option for managing complex cases. This formulation is particularly beneficial in treating infections of the skin, soft tissues, respiratory tract, and urinary tract, among others. The unique composition of Tazomac 2.25 g Injection not only enhances its antibacterial activity but also helps in minimizing the risk of resistance development, making it a preferred choice in clinical settings. With its broad-spectrum action, Tazomac 2.25 g Injection is essential for patients requiring immediate and effective treatment against severe bacterial infections. The therapeutic category of Tazomac 2.25 g Injection emphasizes its role in modern medicine as a critical tool in the fight against antibiotic-resistant bacteria, ensuring that patients receive the best possible care. Overall, Tazomac 2.25 g Injection represents a significant advancement in antibiotic therapy, combining efficacy with safety to support patient recovery and health.
Uses & Benefits
Tazomac 2.25 g Injection effectively treats a variety of bacterial infections.
This formulation is particularly useful for patients with severe infections that require immediate intervention.
Tazomac 2.25 g Injection is indicated for the treatment of skin and soft tissue infections.
It is also effective against respiratory tract infections, including pneumonia.
The medication can be used to manage urinary tract infections caused by susceptible bacteria.
Tazomac 2.25 g Injection helps reduce the risk of complications associated with untreated bacterial infections.
This therapy is beneficial in treating intra-abdominal infections.
Tazomac 2.25 g Injection supports healthcare providers in managing polymicrobial infections.
It is often used in surgical prophylaxis to prevent postoperative infections.
The formulation aids in minimizing the development of antibiotic resistance.
Tazomac 2.25 g Injection enhances patient outcomes through its broad-spectrum activity.
This medication is suitable for use in both adult and pediatric populations when indicated.
Tazomac 2.25 g Injection can be administered in hospital settings for serious infections.
It is an essential option for patients with compromised immune systems.
The formulation provides rapid therapeutic effects due to its intravenous administration.
Tazomac 2.25 g Injection is often part of combination therapy for enhanced efficacy.
How Tazomac 2.25 g Injection works
Tazomac 2.25 g Injection works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. This mechanism makes it effective against a wide range of bacteria.
The active components, piperacillin and tazobactam, work synergistically to enhance antibacterial activity.
Piperacillin disrupts the synthesis of the bacterial cell wall, while tazobactam inhibits beta-lactamase enzymes that would otherwise degrade piperacillin.
This dual action allows Tazomac 2.25 g Injection to target both Gram-positive and Gram-negative bacteria effectively.
The formulation is particularly effective against bacteria that produce beta-lactamase enzymes, which confer resistance to other antibiotics.
By maintaining effective concentrations in the bloodstream, Tazomac 2.25 g Injection ensures sustained antibacterial action throughout treatment.
The rapid onset of action helps in managing acute infections effectively.
Tazomac 2.25 g Injection's mechanism supports its use in severe and complicated infections where other treatments may fail.
How to use Tazomac 2.25 g Injection
Tazomac 2.25 g Injection should be administered intravenously by a healthcare professional.
The recommended dosage for adults typically ranges from 3.375 g to 4.5 g every 6 to 8 hours, depending on the severity of the infection.
For pediatric patients, dosing is usually based on body weight and should be determined by a healthcare provider.
The frequency of administration may vary based on the clinical condition being treated; consult a physician for specific guidance.
Tazomac 2.25 g Injection should be infused over a period of 30 minutes to ensure proper absorption and minimize side effects.
Duration of treatment with Tazomac 2.25 g Injection generally lasts from 7 to 14 days, depending on the infection type and response to therapy.
Special instructions include monitoring renal function during treatment, especially in patients with pre-existing kidney conditions.
Ensure that Tazomac 2.25 g Injection is stored properly at controlled room temperature and protected from light until use.
Lifestyle Advice
Maintain hydration by drinking plenty of fluids while receiving Tazomac 2.25 g Injection to support kidney function.
Avoid consuming alcohol during treatment to minimize side effects and enhance recovery.
Incorporate a balanced diet rich in vitamins and minerals to support overall health during antibiotic therapy.
Engage in light physical activity as tolerated to promote circulation and recovery while on Tazomac 2.25 g Injection.
Follow up with healthcare providers regularly to monitor progress and adjust treatment as necessary.
Side Effects
Side Effects
Common side effects of Tazomac 2.25 g Injection may include nausea and vomiting.
Patients might experience diarrhea as a result of antibiotic therapy.
Allergic reactions such as rash or itching can occur; seek medical attention if severe symptoms develop.
Some individuals may experience changes in liver function tests during treatment with Tazomac 2.25 g Injection.
Serious side effects include anaphylaxis; immediate medical help should be sought if this occurs.
Severe gastrointestinal reactions like Clostridium difficile-associated diarrhea may arise; monitor for symptoms such as severe abdominal pain or bloody stools.
Renal impairment may occur; regular monitoring of kidney function is advised during therapy with Tazomac 2.25 g Injection.
Precautions and Warnings
Precautions & Warnings
Tazomac 2.25 g Injection should not be used in patients with a known allergy to penicillins or cephalosporins.
Patients with a history of severe allergic reactions should inform their healthcare provider before starting treatment.
Caution is advised when administering Tazomac 2.25 g Injection to individuals with renal impairment; dosage adjustments may be necessary.
Pregnant or breastfeeding women should consult their doctor before using Tazomac 2.25 g Injection to assess potential risks and benefits.
Avoid alcohol consumption during treatment as it may exacerbate side effects or reduce effectiveness.
Patients should be monitored for signs of superinfection during prolonged therapy with Tazomac 2.25 g Injection.
Consult a healthcare provider if experiencing unusual symptoms or side effects while using this medication.
1. What is Tazomac 2.25 g Injection used for? Tazomac 2.25 g Injection is primarily used to treat various bacterial infections, including those affecting the skin, respiratory tract, and urinary system.
2. How should Tazomac 2.25 g Injection be administered? This injection should be administered intravenously by a healthcare professional, typically over a period of 30 minutes.
3. What are the common side effects of Tazomac 2.25 g Injection? Common side effects include nausea, vomiting, diarrhea, and potential allergic reactions such as rash.
4. Can I drink alcohol while using Tazomac 2.25 g Injection? It is advisable to avoid alcohol consumption during treatment with Tazomac 2.25 g Injection to reduce side effects.
5. Is Tazomac 2.25 g Injection safe during pregnancy? Pregnant women should consult their healthcare provider before using Tazomac 2.25 g Injection to evaluate potential risks.
6. What should I do if I miss a dose of Tazomac 2.25 g Injection? If a dose is missed, contact your healthcare provider for guidance on how to proceed.
7. Are there any drug interactions with Tazomac 2.25 g Injection? Yes, certain medications may interact with Tazomac 2.25 g Injection; always inform your doctor about all medications you are taking.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
589074
Country of Manufacture
India
Manufacturer Address
Macleods Pharmaceuticals Limited
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Tazomac 2.25 g Injection is a potent pharmaceutical formulation designed for effective therapeutic intervention. This injection contains a carefully balanced composition that primarily includes tazobactam and piperacillin, making it a combination antibiotic that targets a wide range of bacterial infections. Tazomac 2.25 g Injection falls under the category of beta-lactam antibiotics, which are known for their efficacy in treating serious infections caused by susceptible organisms. The primary purpose of Tazomac 2.25 g Injection is to combat infections that are resistant to other antibiotics, providing healthcare professionals with a reliable option for managing complex cases. This formulation is particularly beneficial in treating infections of the skin, soft tissues, respiratory tract, and urinary tract, among others. The unique composition of Tazomac 2.25 g Injection not only enhances its antibacterial activity but also helps in minimizing the risk of resistance development, making it a preferred choice in clinical settings. With its broad-spectrum action, Tazomac 2.25 g Injection is essential for patients requiring immediate and effective treatment against severe bacterial infections. The therapeutic category of Tazomac 2.25 g Injection emphasizes its role in modern medicine as a critical tool in the fight against antibiotic-resistant bacteria, ensuring that patients receive the best possible care. Overall, Tazomac 2.25 g Injection represents a significant advancement in antibiotic therapy, combining efficacy with safety to support patient recovery and health.
Uses & Benefits
Tazomac 2.25 g Injection effectively treats a variety of bacterial infections.
This formulation is particularly useful for patients with severe infections that require immediate intervention.
Tazomac 2.25 g Injection is indicated for the treatment of skin and soft tissue infections.
It is also effective against respiratory tract infections, including pneumonia.
The medication can be used to manage urinary tract infections caused by susceptible bacteria.
Tazomac 2.25 g Injection helps reduce the risk of complications associated with untreated bacterial infections.
This therapy is beneficial in treating intra-abdominal infections.
Tazomac 2.25 g Injection supports healthcare providers in managing polymicrobial infections.
It is often used in surgical prophylaxis to prevent postoperative infections.
The formulation aids in minimizing the development of antibiotic resistance.
Tazomac 2.25 g Injection enhances patient outcomes through its broad-spectrum activity.
This medication is suitable for use in both adult and pediatric populations when indicated.
Tazomac 2.25 g Injection can be administered in hospital settings for serious infections.
It is an essential option for patients with compromised immune systems.
The formulation provides rapid therapeutic effects due to its intravenous administration.
Tazomac 2.25 g Injection is often part of combination therapy for enhanced efficacy.
How Tazomac 2.25 g Injection works
Tazomac 2.25 g Injection works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. This mechanism makes it effective against a wide range of bacteria.
The active components, piperacillin and tazobactam, work synergistically to enhance antibacterial activity.
Piperacillin disrupts the synthesis of the bacterial cell wall, while tazobactam inhibits beta-lactamase enzymes that would otherwise degrade piperacillin.
This dual action allows Tazomac 2.25 g Injection to target both Gram-positive and Gram-negative bacteria effectively.
The formulation is particularly effective against bacteria that produce beta-lactamase enzymes, which confer resistance to other antibiotics.
By maintaining effective concentrations in the bloodstream, Tazomac 2.25 g Injection ensures sustained antibacterial action throughout treatment.
The rapid onset of action helps in managing acute infections effectively.
Tazomac 2.25 g Injection's mechanism supports its use in severe and complicated infections where other treatments may fail.
How to use Tazomac 2.25 g Injection
Tazomac 2.25 g Injection should be administered intravenously by a healthcare professional.
The recommended dosage for adults typically ranges from 3.375 g to 4.5 g every 6 to 8 hours, depending on the severity of the infection.
For pediatric patients, dosing is usually based on body weight and should be determined by a healthcare provider.
The frequency of administration may vary based on the clinical condition being treated; consult a physician for specific guidance.
Tazomac 2.25 g Injection should be infused over a period of 30 minutes to ensure proper absorption and minimize side effects.
Duration of treatment with Tazomac 2.25 g Injection generally lasts from 7 to 14 days, depending on the infection type and response to therapy.
Special instructions include monitoring renal function during treatment, especially in patients with pre-existing kidney conditions.
Ensure that Tazomac 2.25 g Injection is stored properly at controlled room temperature and protected from light until use.
Lifestyle Advice
Maintain hydration by drinking plenty of fluids while receiving Tazomac 2.25 g Injection to support kidney function.
Avoid consuming alcohol during treatment to minimize side effects and enhance recovery.
Incorporate a balanced diet rich in vitamins and minerals to support overall health during antibiotic therapy.
Engage in light physical activity as tolerated to promote circulation and recovery while on Tazomac 2.25 g Injection.
Follow up with healthcare providers regularly to monitor progress and adjust treatment as necessary.
Side Effects
Side Effects
Common side effects of Tazomac 2.25 g Injection may include nausea and vomiting.
Patients might experience diarrhea as a result of antibiotic therapy.
Allergic reactions such as rash or itching can occur; seek medical attention if severe symptoms develop.
Some individuals may experience changes in liver function tests during treatment with Tazomac 2.25 g Injection.
Serious side effects include anaphylaxis; immediate medical help should be sought if this occurs.
Severe gastrointestinal reactions like Clostridium difficile-associated diarrhea may arise; monitor for symptoms such as severe abdominal pain or bloody stools.
Renal impairment may occur; regular monitoring of kidney function is advised during therapy with Tazomac 2.25 g Injection.
Precautions and Warnings
Precautions & Warnings
Tazomac 2.25 g Injection should not be used in patients with a known allergy to penicillins or cephalosporins.
Patients with a history of severe allergic reactions should inform their healthcare provider before starting treatment.
Caution is advised when administering Tazomac 2.25 g Injection to individuals with renal impairment; dosage adjustments may be necessary.
Pregnant or breastfeeding women should consult their doctor before using Tazomac 2.25 g Injection to assess potential risks and benefits.
Avoid alcohol consumption during treatment as it may exacerbate side effects or reduce effectiveness.
Patients should be monitored for signs of superinfection during prolonged therapy with Tazomac 2.25 g Injection.
Consult a healthcare provider if experiencing unusual symptoms or side effects while using this medication.
1. What is Tazomac 2.25 g Injection used for? Tazomac 2.25 g Injection is primarily used to treat various bacterial infections, including those affecting the skin, respiratory tract, and urinary system.
2. How should Tazomac 2.25 g Injection be administered? This injection should be administered intravenously by a healthcare professional, typically over a period of 30 minutes.
3. What are the common side effects of Tazomac 2.25 g Injection? Common side effects include nausea, vomiting, diarrhea, and potential allergic reactions such as rash.
4. Can I drink alcohol while using Tazomac 2.25 g Injection? It is advisable to avoid alcohol consumption during treatment with Tazomac 2.25 g Injection to reduce side effects.
5. Is Tazomac 2.25 g Injection safe during pregnancy? Pregnant women should consult their healthcare provider before using Tazomac 2.25 g Injection to evaluate potential risks.
6. What should I do if I miss a dose of Tazomac 2.25 g Injection? If a dose is missed, contact your healthcare provider for guidance on how to proceed.
7. Are there any drug interactions with Tazomac 2.25 g Injection? Yes, certain medications may interact with Tazomac 2.25 g Injection; always inform your doctor about all medications you are taking.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
589074
Country of Manufacture
India
Manufacturer Address
Macleods Pharmaceuticals Limited
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Related Products
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
